Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Total and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic Patients.

Horáková D, Azeem K, Benešová R, Pastucha D, Horák V, Dumbrovská L, Martínek A, Novotný D, Švagera Z, Hobzová M, Galuszková D, Janout V, Doněvská S, Vrbková J, Kollárová H.

Int J Endocrinol. 2015;2015:545068. doi: 10.1155/2015/545068. Epub 2015 May 5.

2.

Fatty liver disease in diabetes mellitus.

Bhatt HB, Smith RJ.

Hepatobiliary Surg Nutr. 2015 Apr;4(2):101-8. doi: 10.3978/j.issn.2304-3881.2015.01.03. Review.

3.

Persistent organic pollutants as risk factors for type 2 diabetes.

Ngwa EN, Kengne AP, Tiedeu-Atogho B, Mofo-Mato EP, Sobngwi E.

Diabetol Metab Syndr. 2015 Apr 30;7:41. doi: 10.1186/s13098-015-0031-6. eCollection 2015.

4.

Non-alcoholic fatty liver disease: The diagnosis and management.

Abd El-Kader SM, El-Den Ashmawy EM.

World J Hepatol. 2015 Apr 28;7(6):846-58. doi: 10.4254/wjh.v7.i6.846. Review.

5.

Improvement of pulmonary function with arm swing exercise in patients with type 2 diabetes.

Tunkamnerdthai O, Auvichayapat P, Donsom M, Leelayuwat N.

J Phys Ther Sci. 2015 Mar;27(3):649-54. doi: 10.1589/jpts.27.649. Epub 2015 Mar 31.

6.

Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.

Mahajan A, Sim X, Ng HJ, Manning A, Rivas MA, Highland HM, Locke AE, Grarup N, Im HK, Cingolani P, Flannick J, Fontanillas P, Fuchsberger C, Gaulton KJ, Teslovich TM, Rayner NW, Robertson NR, Beer NL, Rundle JK, Bork-Jensen J, Ladenvall C, Blancher C, Buck D, Buck G, Burtt NP, Gabriel S, Gjesing AP, Groves CJ, Hollensted M, Huyghe JR, Jackson AU, Jun G, Justesen JM, Mangino M, Murphy J, Neville M, Onofrio R, Small KS, Stringham HM, Syvänen AC, Trakalo J, Abecasis G, Bell GI, Blangero J, Cox NJ, Duggirala R, Hanis CL, Seielstad M, Wilson JG, Christensen C, Brandslund I, Rauramaa R, Surdulescu GL, Doney AS, Lannfelt L, Linneberg A, Isomaa B, Tuomi T, Jørgensen ME, Jørgensen T, Kuusisto J, Uusitupa M, Salomaa V, Spector TD, Morris AD, Palmer CN, Collins FS, Mohlke KL, Bergman RN, Ingelsson E, Lind L, Tuomilehto J, Hansen T, Watanabe RM, Prokopenko I, Dupuis J, Karpe F, Groop L, Laakso M, Pedersen O, Florez JC, Morris AP, Altshuler D, Meigs JB, Boehnke M, McCarthy MI, Lindgren CM, Gloyn AL; T2D-GENES consortium and GoT2D consortium.

PLoS Genet. 2015 Jan 27;11(1):e1004876. doi: 10.1371/journal.pgen.1004876. eCollection 2015 Jan.

7.

GPS suggests low physical activity in urban Hispanic school children: a proof of concept study.

Carrel AL, Sledge JS, Ventura SJ, Eickhoff JC, Allen DB.

Int J Pediatr Endocrinol. 2014;2014(1):25. doi: 10.1186/1687-9856-2014-25. Epub 2014 Dec 15.

8.

Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity.

Coen PM, Tanner CJ, Helbling NL, Dubis GS, Hames KC, Xie H, Eid GM, Stefanovic-Racic M, Toledo FG, Jakicic JM, Houmard JA, Goodpaster BH.

J Clin Invest. 2015 Jan;125(1):248-57. doi: 10.1172/JCI78016. Epub 2014 Dec 1.

9.

Lifestyle factors associated with type 2 diabetes and use of different glucose-lowering drugs: cross-sectional study.

Ulrichsen SP, Mor A, Svensson E, Larsen FB, Thomsen RW.

PLoS One. 2014 Nov 4;9(11):e111849. doi: 10.1371/journal.pone.0111849. eCollection 2014.

10.

Association between serum irisin levels and non-alcoholic fatty liver disease in health screen examinees.

Choi ES, Kim MK, Song MK, Kim JM, Kim ES, Chung WJ, Park KS, Cho KB, Hwang JS, Jang BK.

PLoS One. 2014 Oct 24;9(10):e110680. doi: 10.1371/journal.pone.0110680. eCollection 2014.

11.

Impact of moderate versus mild aerobic exercise training on inflammatory cytokines in obese type 2 diabetic patients: a randomized clinical trial.

Abd El-Kader S, Gari A, Salah El-Den A.

Afr Health Sci. 2013 Dec;13(4):857-63. doi: 10.4314/ahs.v13i4.1.

12.

Meeting physical activity guidelines is associated with reduced risk for cardiovascular disease in black South African women; a 5.5-year follow-up study.

Dickie K, Micklesfield LK, Chantler S, Lambert EV, Goedecke JH.

BMC Public Health. 2014 May 23;14:498. doi: 10.1186/1471-2458-14-498.

13.

Family history of diabetes, lifestyle factors, and the 7-year incident risk of type 2 diabetes mellitus in middle-aged Japanese men and women.

Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Sasaki S, Nagasawa SY, Morikawa Y, Ishizaki M, Kido T, Naruse Y, Suwazono Y, Nakagawa H.

J Diabetes Investig. 2013 May 6;4(3):261-8. doi: 10.1111/jdi.12033. Epub 2013 Feb 13.

14.

A comprehensive review on metabolic syndrome.

Kaur J.

Cardiol Res Pract. 2014;2014:943162. doi: 10.1155/2014/943162. Epub 2014 Mar 11. Review.

15.

Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.

Sheldon RD, Laughlin MH, Rector RS.

J Appl Physiol (1985). 2014 May 1;116(9):1156-64. doi: 10.1152/japplphysiol.01275.2013. Epub 2014 Feb 27.

16.

Diet and exercise interventions among overweight and obese lactating women: randomized trial of effects on cardiovascular risk factors.

Brekke HK, Bertz F, Rasmussen KM, Bosaeus I, Ellegård L, Winkvist A.

PLoS One. 2014 Feb 7;9(2):e88250. doi: 10.1371/journal.pone.0088250. eCollection 2014.

17.

Cardiorenal metabolic syndrome and diabetic cognopathy.

Hayden MR, Banks WA, Shah GN, Gu Z, Sowers JR.

Cardiorenal Med. 2013 Dec;3(4):265-82. doi: 10.1159/000357113. Epub 2013 Nov 29.

18.

Increases in insulin sensitivity among obese youth are associated with gene expression changes in whole blood.

Miranda DN, Coletta DK, Mandarino LJ, Shaibi GQ.

Obesity (Silver Spring). 2014 May;22(5):1337-44. doi: 10.1002/oby.20711. Epub 2014 Feb 18.

19.

Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain.

Lucha-López MO, Lucha-López AC, Vidal-Peracho C, Tricás-Moreno JM, Estébanez-De Miguel E, Salavera-Bordás C, Hidalgo-García C.

BMC Res Notes. 2014 Jan 21;7:48. doi: 10.1186/1756-0500-7-48.

20.

Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.

Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, Srbecky M, Imrich R, Kyselovicova O, Belan V, Jelok I, Wolfrum C, Klimes I, Krssak M, Zemkova E, Gasperikova D, Ukropec J, Ukropcova B.

J Physiol. 2014 Mar 1;592(Pt 5):1091-107. doi: 10.1113/jphysiol.2013.264655. Epub 2013 Dec 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk